Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients

Summary

The investigators have demonstrated the crucial role of the liver-lung axis in the distant metastasis of NPC. Furthermore, the investigators have identified a potential therapeutic approach to improve outcomes in NPC patients by identifying those most suitable for anticoagulant therapy. Further, the combination of anticoagulant therapy and anti-IL6R therapy has shown promising results in enhancing the prognosis of NPC patients. These findings highlight the significance of targeting the liver-lung axis and utilizing personalized treatment strategies for NPC.

Timeline

Start

2021-08-01

Primary completion

2024-07-01

Completion

2024-07-01

Drugs

Indications